Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,258 signal articles · 44 in last 24h · 115,255 total before filter · latest 2h ago
44last 24h
1803last 7d
299● bullish (7d)
171● bearish (7d)
205publishers
AllMacro322Earnings851M&A104Regulatory25Product16Analyst25
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Major ice cream brand files Chapter 11 bankruptcy after lawsuit
TheStreet3h agobearish
Major ice cream brand files Chapter 11 bankruptcy after lawsuit

Enjoying a serving of frozen dessert on a hot summer day, or at any time for that matter, has grown in popularity as ice cream store industry growth rose by 5.8% to $7.4 billion in the five years through 2025, according to IBISWorld. The industry grew by 0.9% in 2025 alone. Ice cream company ...

Bristol Myers Squibb (BMY) Stock May Be 46% Undervalued As FDA Approval Lands
Simply Wall St.18h agoneutral
Bristol Myers Squibb (BMY) Stock May Be 46% Undervalued As FDA Approval Lands

Bristol-Myers Squibb stock has delivered a 38.1% gain over the past year, while valuation work using a Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples both currently point to the shares trading at a discount to that estimate. For investors, that combination of strong recent returns and a still supportive valuation framework raises the question of how much margin of safety may remain in the current price. The 38.1% one year return shows that sentiment toward...

Bristol Myers Squibb (BMY) Wins FDA Approval, Is The Stock Fully Priced?
Simply Wall St.1d agobullish
Bristol Myers Squibb (BMY) Wins FDA Approval, Is The Stock Fully Priced?

Bristol Myers Squibb (BMY) is back in focus after the FDA granted accelerated approval for ZENBEXUS in a multiple myeloma combination regimen, introducing the first approved CELMoD therapy in this disease setting. See our latest analysis for Bristol-Myers Squibb. The ZENBEXUS approval lands at a time when Bristol-Myers Squibb’s momentum has picked up, with the share price at US$64.65 and a 30 day share price return of 13.52%. That builds on a 20.93% year to date share price return and a...

Loss of Market Share in U.S. Antitrust Consulting Pressures FTI Consulting’s (FCN) Top-Line Performance
Insider Monkey2d agoneutral
Loss of Market Share in U.S. Antitrust Consulting Pressures FTI Consulting’s (FCN) Top-Line Performance

Sycamore Capital Management, a franchise of Victory Capital Management, released its Q2 2026 investor letter for “Sycamore Mid Cap Value Equity Strategy”. A copy of the letter can be downloaded here. Sycamore Capital’s Mid Cap Value investment team focuses on a bottom-up approach to identify undervalued businesses with growth potential. In Q2 2026, the strategy […]

Is Charles Schwab (SCHW) At Greater Risk After A 13,000 Customer Lawsuit?
Simply Wall St.2d agobearish
Is Charles Schwab (SCHW) At Greater Risk After A 13,000 Customer Lawsuit?

Charles Schwab (NYSE:SCHW) faces ongoing litigation from Linqto over an alleged contractual breakdown tied to bankruptcy trust management affecting more than 13,000 customers. Linqto is seeking damages it claims stem from Schwab's role in the disputed trust arrangements during Linqto's bankruptcy process. The dispute centers on alleged contractual breaches that Linqto argues caused substantial harm to impacted customer accounts. The case is drawing attention because of potential reputational...

Investing.com3d agoneutral
Paramount puts CNN sale on table to settle 12-state antitrust suit

Makan Delrahim made the disclosure at Politico’s California Agenda conference, according to Reuters, signaling that Paramount is willing to go beyond internal safeguards to salvage a deal that has become one of the most politically charged media mergers in years. Warner Bros. Discovery is the publicly traded parent of CNN (NASDAQ: WBD), and the merger’s fate directly determines whether Ellison’s Paramount consolidates control over both CBS News and the cable network.

Coinbase, Polymarket, Kalshi Face NYC Prediction Market Investigation
Benzinga Prediction Markets3d agobearish
Coinbase, Polymarket, Kalshi Face NYC Prediction Market Investigation

Coinbase Global Inc. (NASDAQ:COIN) has been swept into New York City’s widening scrutiny of prediction markets, even as the CFTC push back against the state’s attempts to rein in the fast-growing industry. New York City Council Speaker Julie Menin announced...

Millions of consumers could get £70 each after Mastercard lawsuit
Sky News3d agobearish
Millions of consumers could get £70 each after Mastercard lawsuit

Customers can expect payouts of up to £70 as part of a landmark group legal case against Mastercard next year after it settled outside court for £200m. Why is Mastercard paying compensation? The global technology company agreed at the end of last year to pay £200m to settle a legal case launched on behalf of UK consumers a decade ago.

New York City Launches Sweeping Investigation Into Polymarket and Kalshi
The Wall Street Journal3d agobearish
New York City Launches Sweeping Investigation Into Polymarket and Kalshi

The New York City Council is investigating four prediction markets for alleged deceptive marketing practices and targeting minors, opening a new front in the bitter, state-by-state legal war over prediction-market regulation. City Council Speaker Julie Menin sent letters to Polymarket, Kalshi, Coinbase and Gemini Titan, all of which have a presence in New York City, on Aug. 11 seeking answers about how the companies comply with consumer protection laws. In a letter addressed to Polymarket founder and Chief Executive Shayne Coplan, Menin asked for details about Polymarket promotional videos that appeared to depict fake trades and promoted insider trading on social media.

Meta Platforms (META) Opens AI Models As $1 Billion Fund And Lawsuits Add Pressure
Simply Wall St.4d agobearish
Meta Platforms (META) Opens AI Models As $1 Billion Fund And Lawsuits Add Pressure

Meta Platforms (NasdaqGS:META) is pushing to open source superintelligent AI models and has launched Muse Glimmer as part of this effort. Mark Zuckerberg outlined a plan to make advanced AI widely accessible rather than keeping it locked behind premium services. Meta announced a US$1b fund aimed at supporting communities located near its data centers. The 9th Circuit allowed thousands of social media addiction lawsuits against Meta to proceed, increasing legal and regulatory pressure on the...